The influence of home versus clinic anal human papillomavirus sampling on high-resolution anoscopy uptake in the Prevent Anal Cancer Self-Swab Study

BACKGROUND: Anal cancer disproportionately affects men who have sex with men (MSM) living with HIV.

High-resolution anoscopy (HRA) is an in-clinic procedure to detect precancerous anal lesions and cancer, yet prospective data on factors associated with HRA attendance are lacking.

We examined whether anal HPV sampling at home versus in a clinic impacts HRA uptake and assessed HRA acceptability.

METHOD: MSM and trans persons 25 years and older were randomized to home-based self-sampling or clinical sampling.

All were asked to attend in-clinic HRA one year later.

We regressed HRA attendance on study arm using multivariable Poisson regression and assessed HRA acceptability using χ (2) tests.

RESULTS: 62.8% of 196 participants who engaged in screening attended HRA.

Although not significant ( p =0.13), a higher proportion of participants who engaged in clinic-based screening attended HRA (68.5%) compared to home-based participants (57.9%).

Overall, HRA uptake was higher among participants with anal cytology history (aRR 1.44, 95% CI 1.11 – 1.87) and lower among participants preferring versatile anal sex position versus insertive (aRR 0.70, 95% CI 0.53 – 0.91), but did not differ by race or HIV serostatus.

In the clinic arm, persons living with HIV had lower HRA attendance (42.9%) versus HIV-negative participants (73.3%) ( p =0.02) and Black non-Hispanic participants had lower HRA attendance (41.7%) than White non-Hispanic participants (73.1%), ( p =0.04); however, no differences in attendance by race or HIV status were observed in the home arm.

CONCLUSIONS: HRA uptake differed significantly by race and HIV status in the clinic arm but not the home arm.